Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up

Abstract Background The aim of this study was to evaluate long-term efficacy and survival prognostic factors of stereotactic body radiation therapy (SBRT) for un-resectable liver metastases in patients enrolled in a prospective phase II trial. Methods and materials 5-year local control (LC), overall...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marta Scorsetti, Tiziana Comito, Elena Clerici, Ciro Franzese, Angelo Tozzi, Cristina Iftode, Lucia Di Brina, Pierina Navarria, Pietro Mancosu, Giacomo Reggiori, Antonella Fogliata, Stefano Tomatis, Guido Torzilli, Luca Cozzi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2018-11-01
coleção:	Radiation Oncology
Assuntos:	Metastatic liver cancer SBRT SABR Volumetric modulated arc therapy
Acesso em linha:	http://link.springer.com/article/10.1186/s13014-018-1185-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!